Seattle biotech inks licensing deal for opioid abuse treatments

The deal will help the company advance its lead candidate into clinical trials.
guardian.co.tt

America to the rescue

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Two men charged with terror offences after homemade bomb thrown outside NYC mayor's home

The city's police commissioner said one of the suspects said he wanted the attack to be "even larger" than the Boston ...

Memphis company's aggressive 300-plus store expansion plan

The company is investing $1.6 billion in capital expenditures this fiscal year. Much of that is going toward store growth and megahub expansion.
The Caledonian-Record

NUBURU Enters the $20B Global Counter-Drone Defense Market as Lyocon Completes Proof-of-Concept for Portable Directed-Energy Laser Platform

(NYSE American: BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, electronic warfare and software-orchestrated defense systems, today ...